ArticleNeuropsychiatric disease and treatment2022

Brain-Reactive Antibodies are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients.

Xiujiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.